Latest filing published 05 Aug 2024 for Cerevel Therapeutics Holdings, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by John Renger on record concern Cerevel Therapeutics Holdings, Inc., in the capacity of senior executive. Over a trading history stretching from 10 November 2021 to 1 August 2024, the count stands at 56 filings.
Sales make up the whole of the open-market record (29 sales, €15.0M). Outside the open market, there are 26 option exercises. In 2024 alone, the filings show no purchases and 1 sale.
The record was last updated on 5 August 2024 with a transaction in Cerevel Therapeutics Holdings, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
18 of 18 declarations